Targeting bacterial cell division with small molecules and peptides
用小分子和肽靶向细菌细胞分裂
基本信息
- 批准号:10630926
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Bacterial AgentsAntibioticsArchitectureBacteriaBacterial Drug ResistanceBacteriophagesBenzamidesBindingBinding SitesCell divisionCell membraneCellsCytologyDisabled PersonsEnsureEnzymesFoundationsFutureGeneticGram-Negative BacteriaGram-Positive BacteriaGuanosine Triphosphate PhosphohydrolasesHealthHumanLaboratoriesLearningLytic PhaseMembraneMethodsMicroscopyModelingMolecularPeptidesPeptidyltransferasePharmaceutical ChemistryPharmaceutical PreparationsPhysiologicalPolymersProliferatingProtein DynamicsProteinsResistanceTestingTherapeuticantimicrobialbeta-Lactamsdesignefflux pumpinhibitorinsightnovelpathogenic bacteriaprotein complexsmall moleculesmall molecule inhibitorstructural biologyz-ring
项目摘要
Resistance to antibacterial therapies continues to be an urgent threat to human health, particularly bacteria
that are already resistant to multiple antibiotics. To discover and develop new antibacterials, it is important to
find and exploit under-utilized antibiotic targets. One attractive candidate is the divisome, the dynamic protein
complex that splits bacterial cells in two. The bacterial divisome contains a set of highly conserved and
essential proteins that act coordinately to ensure the correct timing and placement of the cell division septum at
mid-cell. The septal transpeptidase is already a target of several widely used beta-lactam antibiotics, but no
other divisome protein is currently targeted. FtsZ, a highly conserved polymer-forming GTPase that forms a
membrane-associated "Z ring" required for organizing the septal transpeptidase and other septum-synthesizing
enzymes, is the only other divisome protein that has been studied extensively as a target of small molecules
and peptides, and our lab has helped to advance the understanding of FtsZ and its interacting proteins for 30
years. Nevertheless, there is still much to learn about how small molecules perturb FtsZ function at the
molecular and cellular level and whether these can lead to potential therapeutics. To address this over-arching
theme, this proposal seeks to define, structurally and physiologically, two different sets of promising new small
molecule inhibitors of FtsZ. The first is a set of two related benzamide derivatives, synthesized by our
medicinal chemistry collaborators, that have high potencies against both Gram-positive bacteria and Gramnegative
bacteria with disabled efflux pumps. These derivatives were synthesized to have optimized binding to
the interdomain cleft (IDC) of FtsZ, a common target of inhibitors that we have termed FtsZ's "Achilles Heel".
Unexpectedly, we found that these two compounds perturb FtsZ by distinct mechanisms in Gram-positive
versus Gram-negative bacteria, prompting the hypothesis that they disrupt FtsZ's ability to assemble into the
proper condensed polymer architecture needed for cell division to progress further. This model will be tested
with our laboratory's unique interdisciplinary array of genetic, cytological, and structural biology methods. The
second set of small molecule inhibitors is a pair of bacteriophage peptides that have evolved to target FtsZ as
part of their lytic cycle. Each peptide binds directly to FtsZ and blocks Z ring assembly, but also binds to
another essential divisome protein that tethers FtsZ to the cytoplasmic membrane. The molecular details of
these binding sites are unknown, but we hypothesize that they do not involve the FtsZ IDC and instead perturb
Z ring assembly by novel two-pronged mechanisms. Again, we will apply our extensive expertise in genetics,
microscopy and structural biology of divisome proteins to elucidate these mechanisms. The insights we will
gain from the proposed studies should lay a foundation for the future therapeutic potential of small molecules
and peptides, potentially in combination with each other or with other antibiotics, to kill bacteria by disrupting
the cell division machinery.
对抗菌疗法的耐药性仍然是对人类健康,特别是细菌健康的紧迫威胁
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Benzodioxane-Benzamides as FtsZ Inhibitors: Effects of Linker's Functionalization on Gram-Positive Antimicrobial Activity.
- DOI:10.3390/antibiotics12121712
- 发表时间:2023-12-08
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM MARGOLIN其他文献
WILLIAM MARGOLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM MARGOLIN', 18)}}的其他基金
Targeting bacterial cell division with small molecules and peptides
用小分子和肽靶向细菌细胞分裂
- 批准号:
10510080 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Mechanisms and Regulation of Cell Division in Bacteria
细菌细胞分裂的机制和调控
- 批准号:
10373994 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Mechanisms and Regulation of Cell Division in Bacteria
细菌细胞分裂的机制和调控
- 批准号:
10590641 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Mechanisms and regulation of cell division in bacteria
细菌细胞分裂的机制和调控
- 批准号:
10379704 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Mechanisms and Regulation of Cell Division in Bacteria
细菌细胞分裂的机制和调控
- 批准号:
9899263 - 财政年份:2019
- 资助金额:
$ 19.5万 - 项目类别:
Targeting and assembly of E. coli cell division proteins
大肠杆菌细胞分裂蛋白的靶向和组装
- 批准号:
7924945 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
Targeting and assembly of E. coli division proteins
大肠杆菌分裂蛋白的靶向和组装
- 批准号:
8303555 - 财政年份:2000
- 资助金额:
$ 19.5万 - 项目类别:
Targeting and assembly of E. coli cell division proteins
大肠杆菌细胞分裂蛋白的靶向和组装
- 批准号:
7283076 - 财政年份:2000
- 资助金额:
$ 19.5万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI CELL DIVISION PROTEINS
大肠杆菌细胞分裂蛋白的靶向和组装
- 批准号:
6797121 - 财政年份:2000
- 资助金额:
$ 19.5万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI CELL DIVISION PROTEINS
大肠杆菌细胞分裂蛋白的靶向和组装
- 批准号:
6651137 - 财政年份:2000
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
- 批准号:
1654774 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8416313 - 财政年份:2012
- 资助金额:
$ 19.5万 - 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8298885 - 财政年份:2012
- 资助金额:
$ 19.5万 - 项目类别: